Status:
UNKNOWN
A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood
Lead Sponsor:
Meir Medical Center
Conditions:
IgG4-related Disease
Aortic Aneurysm
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
IgG4 Related Disease is a multi-systemic fibroenophilic disease that includes a basket of recently discovered medical conditions. The properties that bind them are: lesions similar to tumors in the m...
Detailed Description
IgG4 Related Disease is a multi-systemic fibroenophilic disease that includes a basket of recently discovered medical conditions. The properties that bind them are: lesions similar to tumors in the m...
Eligibility Criteria
Inclusion
- Patients after aneurysm in the aorta
- Men and women aged 18-100 (not including special populations)
- Those who are able to read understand and sign a written consent to participate in the research
Exclusion
- Any patient who does not meet the inclusion criteria
Key Trial Info
Start Date :
November 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03267875
Start Date
November 8 2017
End Date
October 1 2018
Last Update
November 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yael Eizikovits
Kfar Saba, Israel, 44281